Gene-Specific Intron Retention Serves as Molecular Signature that Distinguishes Melanoma from Non-Melanoma Cancer Cells in Greek Patients

Background: Skin cancer represents the most common human malignancy, and it includes BCC, SCC, and melanoma. Since melanoma is one of the most aggressive types of cancer, we have herein attempted to develop a gene-specific intron retention signature that can distinguish BCC and SCC from melanoma bio...

Descripción completa

Detalles Bibliográficos
Autores principales: Giannopoulou, Aikaterini F., Konstantakou, Eumorphia G., Velentzas, Athanassios D., Avgeris, Socratis N., Avgeris, Margaritis, Papandreou, Nikos C., Zoi, Ilianna, Filippa, Vicky, Katarachia, Stamatia, Lampidonis, Antonis D., Prombona, Anastasia, Syntichaki, Popi, Piperi, Christina, Basdra, Efthimia K., Iconomidou, Vassiliki, Papadavid, Evangelia, Anastasiadou, Ema, Papassideri, Issidora S., Papavassiliou, Athanasios G., Voutsinas, Gerassimos E., Scorilas, Andreas, Stravopodis, Dimitrios J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6412294/
https://www.ncbi.nlm.nih.gov/pubmed/30795533
http://dx.doi.org/10.3390/ijms20040937

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6412294/
https://www.ncbi.nlm.nih.gov/pubmed/30795533
http://dx.doi.org/10.3390/ijms20040937

Ejemplares similares